140 related articles for article (PubMed ID: 34258787)
1. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Cuneo A; Rigolin GM; Coscia M; Quaresmini G; Scarfò L; Mauro FR; Motta M; Quaglia FM; Trentin L; Ferrario A; Laurenti L; Reda G; Ferrari A; Pietrasanta D; Sportoletti P; Re F; De Paoli L; Foglietta M; Giordano A; Marchetti M; Farina L; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Malerba L; Ibatici A; Tisi MC; Stefoni V; Leone M; Baratè C; Olivieri J; Murru R; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Levato L; Orsucci L; Penna G; Chiarenza A; Foà R
Hematol Oncol; 2021 Oct; 39(4):570-574. PubMed ID: 34258787
[No Abstract] [Full Text] [Related]
2. Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
Cuneo A; Scarfò L; Reda G; Varettoni M; Quaglia FM; Marchetti M; De Paoli L; Re F; Pietrasanta D; Rigolin GM; Orsucci L; Ibatici A; Gattei V; Mauro FR; Trentin L; Laurenti L; Marasca R; Foà R
Blood; 2020 Aug; 136(6):763-766. PubMed ID: 32559271
[No Abstract] [Full Text] [Related]
3. COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
Del Poeta G; Bomben R; Polesel J; Rossi FM; Pozzo F; Zaina E; Cattarossi I; Varaschin P; Nanni P; Boschian Boschin R; Postorino M; Laureana R; Pasqualone G; Steffan A; Gentile M; Zucchetto A; Gattei V
Hematol Oncol; 2021 Dec; 39(5):712-714. PubMed ID: 34462939
[No Abstract] [Full Text] [Related]
4. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Roeker LE; Eyre TA; Thompson MC; Lamanna N; Coltoff AR; Davids MS; Baker PO; Leslie L; Rogers KA; Allan JN; Cordoba R; Lopez-Garcia A; Antic D; Pagel JM; Martinez-Calle N; García-Marco JA; Hernández-Rivas JÁ; Miras F; Coombs CC; Österborg A; Hansson L; Seddon AN; López Jiménez J; Wilson MR; El-Sharkawi D; Wojenski D; Ma S; Munir T; Valenciano S; Seymour E; Barr PM; Pu J; Patten PEM; Perini GF; Huntington SF; Parry H; Sundaram S; Skarbnik A; Kamdar M; Jacobs R; Walter H; Walewska R; Broom A; Lebowitz S; Isaac KM; Portell CA; Ahn IE; Ujjani CS; Shadman M; Skånland SS; Chong EA; Mato AR
Blood; 2021 Nov; 138(18):1768-1773. PubMed ID: 34297826
[No Abstract] [Full Text] [Related]
5. Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
Blixt L; Bogdanovic G; Buggert M; Gao Y; Hober S; Healy K; Johansson H; Kjellander C; Mravinacova S; Muschiol S; Nilsson P; Palma M; Pin E; Smith CIE; Stromberg O; Sällberg Chen M; Zain R; Hansson L; Österborg A
Leukemia; 2022 Feb; 36(2):476-481. PubMed ID: 34564699
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Chatzikonstantinou T; Kapetanakis A; Scarfò L; Karakatsoulis G; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Bron D; Capasso A; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Del Poeta G; Demosthenous C; Dimou M; Donaldson D; Doubek M; Efstathopoulou M; Eichhorst B; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Gentile M; Gimeno E; Glenthøj A; Gomes da Silva M; Gutwein O; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Karlsson LK; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Milosevic I; Mirás F; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Reda G; Rigolin GM; Ruchlemer R; Saghumyan G; Shrestha A; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Stavroyianni N; Tadmor T; Te Raa D; Tonino SH; Trentin L; Van Der Spek E; van Gelder M; van Kampen R; Varettoni M; Visentin A; Vitale C; Wasik-Szczepanek E; Wróbel T; San Segundo LY; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Stamatopoulos K; Ghia P
Leukemia; 2021 Dec; 35(12):3444-3454. PubMed ID: 34725454
[TBL] [Abstract][Full Text] [Related]
7. Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
Fox TA; Kirkwood AA; Enfield L; O'Reilly M; Arulogun S; D'Sa S; O'Nions J; Kavi J; Vitsaras E; Townsend W; Burns SO; Gohil SH; Cwynarski K; Thomson KJ; Noursadeghi M; Heyderman RS; Rampling T; Ardeshna KM; McCoy LE; Morris EC
Br J Haematol; 2021 Dec; 195(5):706-709. PubMed ID: 34545952
[No Abstract] [Full Text] [Related]
8. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
9. Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
Langerbeins P; Eichhorst B
Acta Haematol; 2021; 144(5):508-518. PubMed ID: 33631756
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.
Langerbeins P; Fürstenau M; Gruell H; Klein F; Persigehl T; Rybniker J; Seeger-Nukpezah T; Kochanek M; Hallek M; Eichhorst B; Koehler P; Böll B
Eur J Haematol; 2020 Oct; 105(4):508-511. PubMed ID: 32575156
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 vaccination in CLL: how often is enough?
Mellinghoff SC; Cornely OA
Blood; 2022 Dec; 140(25):2655-2657. PubMed ID: 36548017
[No Abstract] [Full Text] [Related]
12. Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL experts.
Koffman B; Mato A; Byrd JC; Danilov A; Hedrick B; Ujjani C; Roeker L; Stephens DM; Davids MS; Pagel JM; Shadman M
Am J Hematol; 2020 Aug; 95(8):E199-E203. PubMed ID: 32356356
[No Abstract] [Full Text] [Related]
13. Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.
Sehn LH; Kuruvilla P; Christofides A; Stakiw J
Curr Oncol; 2020 Jun; 27(3):e332-e335. PubMed ID: 32669941
[TBL] [Abstract][Full Text] [Related]
14. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
Morawska M
Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004
[TBL] [Abstract][Full Text] [Related]
15. Vaccination efficacy in patients with chronic lymphocytic leukemia.
Wang KY; Shah P; Skavla B; Fayaaz F; Chi J; Rhodes JM
Leuk Lymphoma; 2023 Jan; 64(1):42-56. PubMed ID: 36270021
[TBL] [Abstract][Full Text] [Related]
16. Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia.
Molica S; Tam C; Polliack A
Hematol Oncol; 2022 Aug; 40(3):313-319. PubMed ID: 35304771
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Harel R; Itchaki G
Acta Haematol; 2024; 147(1):60-72. PubMed ID: 37820599
[TBL] [Abstract][Full Text] [Related]
18. A Case of COVID-19-Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated?
Safarpour D; Srinivasan K; Farooqui M; Roth C; Ghouse M
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):69-72. PubMed ID: 33039356
[No Abstract] [Full Text] [Related]
19. COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now.
Chatzikonstantinou T; Herishanu Y; Montserrat E; Ghia P; Cuneo A; Foà R; Scarfò L
Cancer J; 2021 Jul-Aug 01; 27(4):328-333. PubMed ID: 34398560
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
Haydu JE; Maron JS; Redd RA; Gallagher KME; Fischinger S; Barnes JA; Hochberg EP; Johnson PC; Takvorian RW; Katsis K; Portman D; Ruiters J; Sechio S; Devlin M; Regan C; Blumenthal KG; Banerji A; Judd AD; Scorsune KJ; McGree BM; Sherburne MM; Lynch JM; Weitzman JI; Lei M; Kotton CN; Dighe AS; Maus MV; Alter G; Abramson JS; Soumerai JD
Blood Adv; 2022 Mar; 6(6):1671-1683. PubMed ID: 35073571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
